acyl-coa dehydrogenase, short-chain, deficiency of |
Disease ID | 1992 |
---|---|
Disease | acyl-coa dehydrogenase, short-chain, deficiency of |
Definition | A genetic disorder characterized by deficiency of the enzyme short-chain acyl-coenzyme A dehydrogenase that metabolizes short-chain fatty acids. Signs and symptoms appear in infancy or childhood and may be triggered during fasting or illness. They include vomiting, hypoglycemia, lethargy, hypotonia and failure to thrive. |
Synonym | acads deficiency acadsd acyl-coa dehydrogenase, short-chain deficiency butyryl-coa dehydrogenase deficiency deficiency of butyryl dehydrogenase deficiency of butyryl-coa dehydrogenase deficiency of butyryl-coa dehydrogenase (disorder) deficiency of unsaturated acyl-coa reductase lipid-storage myopathy secondary to short-chain acyl-coa dehydrogenase deficiency scad scad - short chain acyl-coa dehydrogenase deficiency scad deficiency scadh deficiency short chain acyl coa dehydrogenase deficiency short chain acyl coa dehydrogenase deficiency (scad) short chain acyl-coa dehydrogenase deficiency short-chain acyl-coa dehydrogenase deficiency short-chain acyl-coa dehydrogenase deficiency (scad) short-chain acyl-coenzyme a dehydrogenase deficiency short-chain acyl-coenzyme a dehydrogenase deficiency (scad) |
Orphanet | |
OMIM | |
ICD10 | |
UMLS | C0342783 |
SNOMED-CT | |
Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:12) C0009319 | colitis | 9 C0027051 | myocardial infarction | 3 C0027051 | myocardial infarct | 3 C0016052 | fibromuscular dysplasia | 2 C0409974 | lupus erythematosus | 1 C0024796 | marfan's syndrome | 1 C0010068 | coronary artery disease | 1 C0020538 | hypertension | 1 C0155626 | acute mi | 1 C0024141 | systemic lupus erythematosus | 1 C0009782 | connective tissue disorder | 1 C0009782 | connective tissue disorders | 1 |
Curated Gene | Entrez_id | Symbol | Resource(Total Genes:1) |
Inferring Gene | Entrez_id | Symbol | Resource(Total Genes:2) |
Text Mined Gene | Entrez_id | Symbol | Score | Resource(Total Genes:14) 34 | ACADM | 3.247 | DISEASES 36 | ACADSB | 4.109 | DISEASES 37 | ACADVL | 2.766 | DISEASES 205 | AK4 | 2.145 | DISEASES 875 | CBS | 1.748 | DISEASES 1376 | CPT2 | 1.218 | DISEASES 2108 | ETFA | 3.147 | DISEASES 3030 | HADHA | 2.323 | DISEASES 3155 | HMGCL | 3.403 | DISEASES 5053 | PAH | 2.352 | DISEASES 1468 | SLC25A10 | 4.487 | DISEASES 10165 | SLC25A13 | 3.609 | DISEASES 29110 | TBK1 | 2.515 | DISEASES 23038 | WDTC1 | 1.848 | DISEASES |
Locus | (Waiting for update.) |
Disease ID | 1992 |
---|---|
Disease | acyl-coa dehydrogenase, short-chain, deficiency of |
Integrated Phenotype | HPO | Name(Total Integrated Phenotypes:17) HP:0000750 | Late-onset speech development HP:0001252 | Hypotonia HP:0001250 | Seizures HP:0000544 | CPEO HP:0003198 | Myopathic changes HP:0002500 | Leukoaraiosis HP:0001371 | Flexion contractures of joints HP:0001263 | Developmental retardation HP:0003219 | Ethylmalonic aciduria HP:0001254 | Lethargy HP:0002650 | Scoliosis HP:0000709 | Psychosis HP:0001508 | Weight faltering HP:0004911 | Episodic metabolic acidosis HP:0010628 | Facial palsy, unilateral or bilateral HP:0001638 | Cardiomyopathy HP:0008872 | Feeding difficulties in infancy |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:11) HP:0002583 | Colitis | 9 HP:0001658 | Myocardial infarction | 4 HP:0001297 | Cerebral vascular events | 2 HP:0001289 | Confusion | 1 HP:0003287 | Abnormality of mitochondrial metabolism | 1 HP:0001677 | Coronary artery disease | 1 HP:0000822 | Hypertension | 1 HP:0002597 | Abnormality of blood vessels | 1 HP:0001907 | Thromboembolic disease | 1 HP:0005294 | Arterial dissection | 1 HP:0002725 | Systemic lupus erythematosus | 1 |
Disease ID | 1992 |
---|---|
Disease | acyl-coa dehydrogenase, short-chain, deficiency of |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
Text Mining Genotype(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
All Snps(Total Genotypes:23) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs121908003 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120727115 | C | T |
rs121908004 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120737049 | G | T |
rs121908005 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120737043 | G | A |
rs121908006 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120738859 | C | T |
rs147442301 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120727143 | C | T |
rs1799958 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120738280 | G | A |
rs1800556 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120737875 | C | T |
rs28940872 | 9499414 | 35 | ACADS | umls:C0342783 | UNIPROT | Expression of the variant R147W SCAD protein, encoded by the 511T-625G allele, in COS-7 cells showed 45% activity at 37 degrees C in comparison with the wild-type protein, comparable levels of activity at 26 degrees C, and 13% activity when incubated at 41 degrees C. This temperature profile is different from that observed for the variant G185S SCAD protein, encoded by the 511C-625A allele, where higher than normal activity was found at 26 and 37 degrees C, and 58% activity was present at 41 degrees C. These results corroborate the notion that the 511C-625A variant allele is one of the possible underlying causes of ethylmalonic aciduria, and suggest that the 511C-->T mutation represents a second susceptibility variation in the SCAD gene. | 0.562714419 | 1998 | ACADS | 12 | 120739356 | C | T |
rs28940872 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120739356 | C | T |
rs28940874 | 11134486 | 35 | ACADS | umls:C0342783 | UNIPROT | Our findings document that patients carrying these SCAD gene variations may develop clinically relevant SCAD deficiency, and that patients with even mild ethylmalonic aciduria should be tested for these variations. | 0.562714419 | 2001 | ACADS | 12 | 120737939 | C | T |
rs28940874 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120737939 | C | T |
rs28940875 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120739347 | C | G,T |
rs28940875 | 11134486 | 35 | ACADS | umls:C0342783 | UNIPROT | Our findings document that patients carrying these SCAD gene variations may develop clinically relevant SCAD deficiency, and that patients with even mild ethylmalonic aciduria should be tested for these variations. | 0.562714419 | 2001 | ACADS | 12 | 120739347 | C | G,T |
rs28941773 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120739168 | C | T |
rs28941773 | 11134486 | 35 | ACADS | umls:C0342783 | UNIPROT | Our findings document that patients carrying these SCAD gene variations may develop clinically relevant SCAD deficiency, and that patients with even mild ethylmalonic aciduria should be tested for these variations. | 0.562714419 | 2001 | ACADS | 12 | 120739168 | C | T |
rs387906308 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120737085 | GAG | - |
rs387906950 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120739141 | A | G |
rs387906951 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120737098 | G | A |
rs57443665 | 9499414 | 35 | ACADS | umls:C0342783 | UNIPROT | Expression of the variant R147W SCAD protein, encoded by the 511T-625G allele, in COS-7 cells showed 45% activity at 37 degrees C in comparison with the wild-type protein, comparable levels of activity at 26 degrees C, and 13% activity when incubated at 41 degrees C. This temperature profile is different from that observed for the variant G185S SCAD protein, encoded by the 511C-625A allele, where higher than normal activity was found at 26 and 37 degrees C, and 58% activity was present at 41 degrees C. These results corroborate the notion that the 511C-625A variant allele is one of the possible underlying causes of ethylmalonic aciduria, and suggest that the 511C-->T mutation represents a second susceptibility variation in the SCAD gene. | 0.562714419 | 1998 | ACADS | 12 | 120737893 | T | C,G |
rs57443665 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120737893 | T | C,G |
rs61732144 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120737094 | C | T |
rs752677472 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120737404 | C | G,T |
rs786204691 | NA | 35 | ACADS | umls:C0342783 | CLINVAR | NA | 0.562714419 | NA | ACADS | 12 | 120738337 | GA | - |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:7) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0003219 | Ethylmalonic aciduria | MP:0010028 | aciduria | excretion of an acid urine |
HP:0002500 | Abnormality of the cerebral white matter | MP:0012129 | failure of blastocyst formation | inability to form a blastocyst from a solid ball of cells known as a morula |
HP:0008872 | Feeding difficulties in infancy | MP:0011075 | abnormal macrophage activation involved in immune response | anomaly in the process in which a change in response and behavior of a macrophage results from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response |
HP:0001508 | Failure to thrive | MP:0013294 | prenatal lethality prior to heart atrial septation | death prior to the completion of heart atrial septation (Mus: E14.5-15.5) |
HP:0001263 | Global developmental delay | MP:0002084 | abnormal developmental patterning | abnormal systematic arrangement of the developing body along an axis |
HP:0001252 | Muscular hypotonia | MP:0004144 | hypotonia | decreased muscle tension resulting in limpness of the muscles in the resting state, not to be confused with weakness |
HP:0000750 | Delayed speech and language development | MP:0012251 | abnormal diaphragm development | malformation or incomplete differentiation of the thin musculomembranous barrier separating the abdominal and thoracic cavities and functioning in respiration |
Mapped by homologous gene(Total Items:17) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0001252 | Muscular hypotonia | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0002650 | Scoliosis | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0000544 | External ophthalmoplegia | MP:0020214 | susceptible to malignant hyperthermia | increased susceptibility to hyperthermia triggered by exposure to certain drugs used for general anesthesia, specifically the volatile anesthetic agents and the neuromuscular blocking agent, succinylcholine |
HP:0003198 | Myopathy | MP:0020280 | increased creatine kinase level | increased level of the enzyme that catalyzes the reversible transfer of creatine to phosphocreatine |
HP:0001263 | Global developmental delay | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0003219 | Ethylmalonic aciduria | MP:0013659 | abnormal erythroid lineage cell morphology | any structural anomaly of an immature or mature cell in the lineage leading to and including erythrocytes |
HP:0001508 | Failure to thrive | MP:0020234 | decreased basal metabolism | decrease in heat production of an organism at the lowest level of cell chemistry in an inactive, awake, and fasting state |
HP:0010628 | Facial palsy | MP:0020240 | increased skeletal muscle cell apoptosis | increase in the number of skeletal muscle cells undergoing programmed cell death |
HP:0000750 | Delayed speech and language development | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0000709 | Psychosis | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0001250 | Seizures | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0001254 | Lethargy | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0001638 | Cardiomyopathy | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0002500 | Abnormality of the cerebral white matter | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0008872 | Feeding difficulties in infancy | MP:0020214 | susceptible to malignant hyperthermia | increased susceptibility to hyperthermia triggered by exposure to certain drugs used for general anesthesia, specifically the volatile anesthetic agents and the neuromuscular blocking agent, succinylcholine |
HP:0001371 | Flexion contracture | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0004911 | Episodic metabolic acidosis | MP:0011632 | dilated mitochondria | the luminal space of the mitochondria is increased in volume or area, usually with an increase of contained fluid |
Disease ID | 1992 |
---|---|
Disease | acyl-coa dehydrogenase, short-chain, deficiency of |
Case | (Waiting for update.) |